Movex SR Tablet (Sustained Release) 200 mg

Movex SR is a sustained-release tablet containing 200 mg Aceclofenac, a potent NSAID manufactured by Opsonin Pharma Ltd. Priced at ৳7.00 per unit (৳70.00 per strip), it offers extended relief for osteoarthritis, rheumatoid arthritis, and inflammatory pain. The drug inhibits cyclooxygenase enzymes, reducing prostaglandin production to alleviate inflammation and discomfort.

Available as a sustained-release tablet, Movex SR requires once-daily dosing. Adults should take one 200 mg tablet orally, preferably after meals. For acute pain, doctors may recommend standard film-coated Aceclofenac tablets (100 mg twice daily). Always consult a physician before combining it with diuretics, anticoagulants, or lithium.

Common side effects include mild indigestion, abdominal pain, and skin rashes. Prolonged use may increase cardiovascular risks. Store tablets in dry conditions (below 30°C) away from children. Pregnant women should avoid NSAIDs unless benefits outweigh fetal risks. For alternatives, explore other Drugs for Osteoarthritis or consult Medexly’s generic medicine database.

With its cost-effective pricing (3×10 pack: ৳210), Movex SR balances efficacy and affordability. Patients seeking sustained pain management often prefer this formulation over immediate-release options. Monitor renal function during long-term therapy and report any unusual bleeding or allergic reactions immediately.

Extended Release: 200mg once daily. Film-Coated: 100mg twice daily. Dose adjustment needed in renal/hepatic impairment. Take after meals. Avoid prolonged use beyond 2 weeks without medical supervision.

Movex SR is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.

Pregnancy Category C/D. Contraindicated in 3rd trimester. Excreted in breast milk – avoid during lactation. Fetal cardiovascular risks warrant caution.

Monitor CBC/LFT with prolonged use. Consider gastroprotection with misoprostol. Abrupt discontinuation may cause rebound pain. Use lowest effective dose for shortest duration.

Start with lowest dose in geriatrics. Contraindicated in severe renal impairment (GFR <30). Reduce dose by 50% in hepatic cirrhosis. No pediatric safety data.